LLY

906.48

-1.97%↓

UNH

577.95

-2%↓

NVO

131.97

-3.67%↓

JNJ

167.31

+0.18%↑

ABBV

193.29

-1.3%↓

LLY

906.48

-1.97%↓

UNH

577.95

-2%↓

NVO

131.97

-3.67%↓

JNJ

167.31

+0.18%↑

ABBV

193.29

-1.3%↓

LLY

906.48

-1.97%↓

UNH

577.95

-2%↓

NVO

131.97

-3.67%↓

JNJ

167.31

+0.18%↑

ABBV

193.29

-1.3%↓

LLY

906.48

-1.97%↓

UNH

577.95

-2%↓

NVO

131.97

-3.67%↓

JNJ

167.31

+0.18%↑

ABBV

193.29

-1.3%↓

LLY

906.48

-1.97%↓

UNH

577.95

-2%↓

NVO

131.97

-3.67%↓

JNJ

167.31

+0.18%↑

ABBV

193.29

-1.3%↓

Search

aTyr Pharma Inc

Fermé

1.84 -3.66

Résumé

Variation du prix de l'action

24h

Actuel

Min

1.83

Max

1.91

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+973.3 upside

aTyr Pharma Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

17 sept. 2024, 23:10 UTC

Actualités

Bank of Canada Welcomes 2% Inflation, Pivoting Focus to Growth

17 sept. 2024, 16:37 UTC

Résultats

Correction to Walmart Headlines on Aug. 15

17 sept. 2024, 16:21 UTC

Acquisitions, Fusions, Rachats

Generali Agrees to Sale of Turkish Business

17 sept. 2024, 16:03 UTC

Résultats

Correction to Estee Lauder Headline on Aug. 19

17 sept. 2024, 21:45 UTC

Actualités

UAW Clashes With Jeep Maker Stellantis Over Promised Factory Work -- WSJ

17 sept. 2024, 21:20 UTC

Actualités

Fed's 'Reverse Repo' Balance Fell to Lowest in Over 3 Years. Why It Matters. -- Barrons.com

17 sept. 2024, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

17 sept. 2024, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 sept. 2024, 20:38 UTC

Actualités

The Stock Market Is Priced for Middling Returns No Matter What the Fed Does -- Barrons.com

17 sept. 2024, 20:24 UTC

Actualités

U.S. Stocks Pare Gains; Traders Betting on Big Fed Cut -- WSJ

17 sept. 2024, 20:05 UTC

Actualités

Meta Extends Ray-Ban Partnership; Zuckerberg Says Glasses 'Next Major Tech Platform' -- IBD

17 sept. 2024, 20:00 UTC

Actualités

JPMorgan in Talks With Apple to Take Over Credit Card From Goldman -- 2nd Update

17 sept. 2024, 19:33 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

17 sept. 2024, 19:28 UTC

Actualités

U.S. Stocks Give Up Gains; Traders Still Betting on Big Fed Cut -- WSJ

17 sept. 2024, 19:10 UTC

Actualités

Forget the Fed. This is the Stock Market's Biggest Risk. -- Barrons.com

17 sept. 2024, 19:08 UTC

Market Talk

Oil Futures Rise on Renewed Middle East Tensions -- Market Talk

17 sept. 2024, 18:21 UTC

Market Talk

Gold Down As Investors Await Fed Decision -- Market Talk

17 sept. 2024, 18:06 UTC

Market Talk

Barrick CEO Argues Valuation Case as Company Targets Growth -- Market Talk

17 sept. 2024, 17:36 UTC

Market Talk

Steel Industry Challenges on Display Amid Warning from Nucor -- Market Talk

17 sept. 2024, 17:32 UTC

Market Talk

Oil Futures Press Higher On Lebanon, Fed Watch -- Market Talk

17 sept. 2024, 17:07 UTC

Market Talk

Canada Housing Construction To Remain Weak Through 2024 -- Market Talk

17 sept. 2024, 17:04 UTC

Acquisitions, Fusions, Rachats

Workday Is Buying Evisort in Move Into AI-Based Document Intelligence -- Barrons.com

17 sept. 2024, 17:03 UTC

Actualités

JPMorgan in Talks With Apple to Take Over Credit Card From Goldman -- Update

17 sept. 2024, 16:43 UTC

Market Talk

Treasury Yields Rise As U.S. Indicators Show Strength -- Market Talk

17 sept. 2024, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

17 sept. 2024, 16:11 UTC

Actualités

JPMorgan in Talks With Apple to Take Over Credit Card From Goldman -- WSJ

17 sept. 2024, 16:04 UTC

Actualités

U.S. Stock Indexes Rise; Traders Still Betting on Big Fed Cut -- WSJ

17 sept. 2024, 15:57 UTC

Market Talk

Bank of Canada 'Completely Behind the Curve' -- Market Talk

17 sept. 2024, 15:50 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 sept. 2024, 15:50 UTC

Market Talk

Hitting 2% Inflation Not Enough to Justify Faster, Deeper Canada Rate Cuts -- Market Talk

Comparaison

Variation de prix

aTyr Pharma Inc prévision

Objectif de Prix

By TipRanks

973.3% hausse

Prévisions sur 12 Mois

Moyen 20.5 USD  973.3%

Haut 35 USD

Bas 9 USD

Basé sur 4 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

4 ratings

4

Achat

0

Maintien

0

Vente